| Financial Year |
March 31 2023 |
| Monetary Funds |
546,189,884.44 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
628,257,755.66 |
| Advances to Suppliers |
414,647,599.71 |
| Other Receivables |
655,196,601.24 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
5,747,231,242.91 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
115,707,082.27 |
| Other Current Assets |
140,145,602.48 |
| Total Current Assets |
10,773,893,706.80 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
350,433,401.22 |
| Long-term Equity Investment |
69,188,060.28 |
| Investment Properties |
3,696,985.64 |
| Fixed Assetes |
3,604,467,881.05 |
| Under-construction Projects |
341,065,169.18 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,103,452,756.19 |
| R&D expenses |
-- |
| Goodwill |
494,620,642.21 |
| Long-Term Deferred and Prepaid Expenses |
72,858,151.86 |
| Deferred Income Tax Assets |
26,614,573.80 |
| Other Non-Current Assets |
166,743,653.06 |
| Sub-Total of Non-Current Assets |
6,254,688,695.57 |
| Total Assets |
17,028,582,402.37 |
| Short-Term Loans |
2,220,790,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
367,223,894.55 |
| Accounts Payable |
1,627,601,186.23 |
| Accounts Received In Advance |
9,722,877.36 |
| Employee Compensation Payable |
5,710,193.18 |
| Taxes Payable |
103,530,900.20 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
199,636,867.17 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
198,670,520.99 |
| Other Current Liabilities |
160,919,117.44 |
| Sub-Total of Current Liabilities |
5,274,970,440.24 |
| Long-term Loans |
2,379,336,916.24 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
11,109,350.85 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,418,348,448.03 |
| Total Liabilities |
7,693,318,888.27 |
| Paid-In Capital(Or Share Stock) |
1,804,213,109.00 |
| Capital Surplus |
5,606,192,612.92 |
| Surplus Reserve |
354,304,567.85 |
| LESS:Treasury Stock |
179,319,054.10 |
| Undistributed Profits |
1,704,813,627.54 |
| Minority Stockholder's Interest |
45,058,650.89 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
9,290,204,863.21 |
| Owner's Equity（Stockholder's Equity） |
9,335,263,514.10 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
17,028,582,402.37 |
